Exploring the connection between stroke and Alzheimer's disease through cellular mechanisms
Official title: Dissecting the Molecular Link Between Stroke, Actin, and Alzheimer's Disease
Funded at University of Rhode Island · NIH-10772704 · Data updated 2026-11-12
This study is looking at how having a stroke might raise the chances of getting Alzheimer's disease by exploring changes in brain cells, and it hopes to find new ways to help prevent or treat Alzheimer's for people who have had a stroke.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rhode Island NIH-funded |
| Lab location | 1 site (Kingston, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $413,729 |
| NIH project number | 1R21NS134813-01 |
| Project ID | NIH-10772704 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults who have suffered a stroke and are at risk for developing Alzheimer's disease.
✕Less likely to help
Patients who have not experienced a stroke or do not have risk factors for Alzheimer's disease may not benefit from this research.
What this research studies
This research investigates how stroke may increase the risk of developing Alzheimer's disease by examining the molecular changes that occur in neurons after a stroke. It focuses on the role of the actin cytoskeleton and how its alterations can affect neuronal health and survival. By understanding these cellular processes, the research aims to uncover the long-term impacts of stroke on brain function and the development of neurodegenerative diseases. Patients may benefit from insights that could lead to new therapeutic strategies for preventing or treating Alzheimer's disease.
Why it matters
Potential benefit: If successful, this research could lead to new ways to prevent or treat Alzheimer's disease in patients who have experienced a stroke.
How similar studies have gone: Previous research has shown promising results in understanding the links between stroke and neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
-
University of Rhode Island
Kingston, United States Active
Researchers
- Principal investigator: Fallini, Claudia — University of Rhode Island
- Study coordinator: Fallini, Claudia
Related research
Other NIH-funded projects on the same topics.
-
Investigating how breathing problems after a stroke affect thinking skills in older adults with Alzheimer's disease.
This study is looking at how breathing problems after a stroke might affect thinking and memory in older adults, especially those with Alzheimer's or certain brain conditions, to find ways to help improve both breathing and brain health.
-
How vascular risk factors affect the risk of Alzheimer's disease after a stroke
This study is looking at how things like high blood pressure, diabetes, and high cholesterol might affect the chances of stroke survivors developing Alzheimer's disease, so we can find better ways to help keep their brains healthy.
-
Investigating the link between atrial fibrillation and Alzheimer's disease
This study is looking at how atrial fibrillation (AF) might affect thinking and memory in people, even if they haven't had a stroke, by checking for certain markers in the blood that are linked to Alzheimer's disease, with the hope of finding new ways to help prevent and manage dementia for those with AF.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.